Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
https://doi.org/10.21292/2075-1230-2019-97-7-21-27
Abstract
About the Authors
R. Yu. АbdullаevRussian Federation
Rizvan Yu. Аbdullaev - Doctor of Medical Sciences, Professor, Leading Researcher of Department for Pathological Anatomy, Electronic Microscopy and Biochemistry, Head of Biochemical Laboratory.
2, Yauzskaya Alleya, Moscow, 107564, Phone: +7 (499) 748-30-23
O. G. Komissаrovа
Russian Federation
Oksana G. Komissarova - Doctor of Medical Sciences, Deputy Director for Research and Therapy.
2, Yauzskaya Alleya, Moscow, 107564, Phone: +7 (499) 785-90-60
E. S. Chumаkovа
Russian Federation
Elena S. Chumakova - Head of Therapy Department.
56, Dostoevskiy St., Stavropol, 355019, Phone/Fax: +7 (8652) 28-83-60
V. S. Odinets
Russian Federation
Vasiliy S. Odinets - Head Physician.
56, Dostoevskiy St., Stavropol, 355019, Phone/Fax: +7 (8652) 28-83-60
A. E. Ergeshov
Russian Federation
Atadzhan E. Ergeshov - Doctor of Medical Sciences, Professor, Director.
2, Yauzskaya Alleya, Moscow, 107564, Phone: +7 (499) 785-90-19
References
1. Аbdullaev R.Yu., Vaniev E.V., Kaminskaya G.O., Vasilyeva I.А., Komissarova O.G. Evaluation of functional liver state in patients suffering from new pulmonary tuberculosis when using I and IIB chemotherapy regimens. Probl. Tub., 2009, no. 2, pp. 57-61. (In Russ.)
2. Ivanova D.А., Borisov S.E., Ryzhov А.M. et al. Frequency and risk of severe adverse reactions during treatment of newly detected tuberculosis patients. Tuberculosis and Lung Diseases, 2012, vol. 90, no. 12, pp. 15-22. (In Russ.)
3. Samoylova А.G., Burakova M.V., Vasilyeva I.А., Lenskaya V.V., Vaniev E.V. The impact of express rifampicin susceptibility testing on chemotherapy efficiency in those suffering from multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 9, pp. 18-23. (In Russ.)
4. Federalnye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya. [Federal recommendations for diagnostics and treatment of respiratory tuberculosis]. Moscow, Tver, OOO Triada Publ., 2014, 56 p.
5. Ergeshov А.E., Komissarova O.G. Podkhody k lecheniyu bolnykh tuberkulezom legkikh s mnozhestvennoy i shirokoy lekarstvennoy ustojchivostyu vozbuditelya. Federalny spravochnik. Zdravookhranenie Rossii. [Approaches to treatment of pulmonary tuberculosis patients with multiple or extensive drug resistance. Federal reference book. Healthcare of Russia]. 2017, Issue 17, pp. 175-179.
6. Common Terminology Criteria for Adverse Events v4.0 (CTCAE). Publish Date: May 28, 2009. http://www.meddramsso.com
7. Weyer K. Mirzayev F., Migliori G. et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur. Respir. J., 2013, vol. 42, pp. 252-271.
Review
For citations:
Аbdullаev R.Yu., Komissаrovа O.G., Chumаkovа E.S., Odinets V.S., Ergeshov A.E. Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2019;97(7):21-27. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-7-21-27